title: Regulation of rat MOR-1 gene expression after chronic intracerebroventricular             administration of morphine.
abstract: The µ-opioid receptor is the primary site for the action of morphine. In the present study, we investigated the regulation of the µ-opioid receptor mRNA levels in the locus ceruleus, ventral tegmental area, nucleus accumbens and hypothalamus of the rat brain following intracerebroventricular administration of morphine for 7 days. The isolated mRNA from these regions was subjected to real-time quantitative RT-PCR to determine the regulation of µ-opioid receptor gene expression. It was observed that 7 days of treatment with morphine significantly down-regulated the µ-opioid receptor mRNA levels in the hypothalamus of the brain in comparison to the control group. However, the µ-opioid receptor levels in the locus ceruleus, ventral tegmental area and nucleus accumbens regions remained the same as the control levels. Down-regulation of µ-opioid receptor mRNA levels in the hypothalamus region of the brain indicates the probable role of opioids to influence neuroendocrine function. The results further indicate that cellular adaptation for morphine tolerance is tissue-specific. These findings help us to understand the mechanism of morphine tolerance in various regions of the brain.
authors.affiliation: College of Pharmacy and Pharmaceutical Sciences, Florida A and M University, Tallahassee, FL 32307, USA.
authors.forename: Zhi-Ping
authors.initials: ZP
authors.lastname: Zhu
authors.forename: Ramesh B
authors.initials: RB
authors.lastname: Badisa
authors.forename: Donald E
authors.initials: DE
authors.lastname: Palm
authors.forename: Carl B
authors.initials: CB
authors.lastname: Goodman
mesh_terms: D000818:Animals; D005786:Gene Expression Regulation / Q000187:drug effects*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D057967:Infusions, Intraventricular; D008297:Male; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009294:Narcotics / Q000008:administration & dosage / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017450:Receptors, Opioid, mu / Q000235:genetics / Q000378:metabolism*
chemical_list: D009294:Narcotics; C485765:Oprm1 protein, rat; D012333:RNA, Messenger; D017450:Receptors, Opioid, mu; D009020:Morphine
references.citation: Eur J Pharmacol. 1990 Nov 13;190(3):305-11
references.pmid: 2176984
references.citation: Peptides. 1990 Mar-Apr;11(2):277-80
references.pmid: 2356156
references.citation: Brain Res. 1990 Sep 3;526(2):270-5
references.pmid: 2175241
references.citation: J Neurosci. 2002 Sep 15;22(18):8312-23
references.pmid: 12223586
references.citation: Peptides. 1996;17(3):389-97
references.pmid: 8735964
references.citation: Brain Res. 1989 Jan 16;477(1-2):382-6
references.pmid: 2539233
references.citation: Ann N Y Acad Sci. 2002 Jun;965:487-96
references.pmid: 12105124
references.citation: J Pharmacol Exp Ther. 2001 Apr;297(1):11-8
references.pmid: 11259522
references.citation: Neuroreport. 1995 Mar 27;6(5):725-9
references.pmid: 7605935
references.citation: J Biol Chem. 2003 Nov 14;278(46):45978-86
references.pmid: 12939277
references.citation: J Neurosci. 1996 Apr 15;16(8):2684-92
references.pmid: 8786444
references.citation: Neurochem Res. 1996 Nov;21(11):1469-88
references.pmid: 8947936
references.citation: Annu Rev Pharmacol Toxicol. 1990;30:123-47
references.pmid: 2160790
references.citation: Peptides. 1989 May-Jun;10(3):499-522
references.pmid: 2550910
references.citation: Eur J Pharmacol. 1991 Jun 6;198(2-3):157-63
references.pmid: 1650700
references.citation: Prog Neurobiol. 1996 Mar-Apr;48(4-5):461-87
references.pmid: 8804117
references.citation: Biopolymers. 2000;55(4):334-46
references.pmid: 11169924
references.citation: Clin Exp Pharmacol Physiol. 2001 Mar;28(3):147-54
references.pmid: 11207668
references.citation: Life Sci. 1993;52(21):1685-93
references.pmid: 8388977
references.citation: Neuron. 1999 Aug;23(4):737-46
references.pmid: 10482240
references.citation: FEBS Lett. 1994 Nov 7;354(2):213-6
references.pmid: 7957926